CN86102398A - 取代苯并咪唑衍生物的制备方法 - Google Patents

取代苯并咪唑衍生物的制备方法 Download PDF

Info

Publication number
CN86102398A
CN86102398A CN86102398A CN86102398A CN86102398A CN 86102398 A CN86102398 A CN 86102398A CN 86102398 A CN86102398 A CN 86102398A CN 86102398 A CN86102398 A CN 86102398A CN 86102398 A CN86102398 A CN 86102398A
Authority
CN
China
Prior art keywords
compound
formula
group
methyl
pyrimidylmethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN86102398A
Other languages
English (en)
Chinese (zh)
Inventor
罗伯特·约翰·艾夫
托马斯·亨利·布朗
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Smith Kline and French Laboratories Ltd
Original Assignee
Smith Kline and French Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB858505615A external-priority patent/GB8505615D0/en
Priority claimed from GB858531605A external-priority patent/GB8531605D0/en
Application filed by Smith Kline and French Laboratories Ltd filed Critical Smith Kline and French Laboratories Ltd
Publication of CN86102398A publication Critical patent/CN86102398A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CN86102398A 1985-03-05 1986-03-05 取代苯并咪唑衍生物的制备方法 Pending CN86102398A (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB858505615A GB8505615D0 (en) 1985-03-05 1985-03-05 Heterocyclic compounds
GB8505615 1985-03-05
GB858531605A GB8531605D0 (en) 1985-12-23 1985-12-23 Heterocyclic compounds
GB8531605 1985-12-23

Publications (1)

Publication Number Publication Date
CN86102398A true CN86102398A (zh) 1986-11-12

Family

ID=26288907

Family Applications (1)

Application Number Title Priority Date Filing Date
CN86102398A Pending CN86102398A (zh) 1985-03-05 1986-03-05 取代苯并咪唑衍生物的制备方法

Country Status (16)

Country Link
US (2) US4777172A (https=)
EP (1) EP0198583A1 (https=)
CN (1) CN86102398A (https=)
AU (1) AU578141B2 (https=)
DK (2) DK93986A (https=)
ES (1) ES8707949A1 (https=)
FI (1) FI860909A7 (https=)
GR (1) GR860596B (https=)
HU (1) HU195962B (https=)
IL (1) IL78026A (https=)
JO (1) JO1443B1 (https=)
NO (1) NO860830L (https=)
NZ (1) NZ215362A (https=)
PH (2) PH23115A (https=)
PT (1) PT82135B (https=)
ZW (1) ZW4786A1 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0174717B1 (en) * 1984-07-06 1992-01-22 FISONS plc Benzimidazoles, and their production formulation and use as gastric acid secretion inhibitors
DE3723327A1 (de) * 1987-07-15 1989-02-02 Hoechst Ag Substituierte thienoimidazol-derivate, verfahren zu ihrer herstellung, sie enthaltende pharmazeutische zubereitungen und ihre verwendung als magensaeuresekretionshemmer, magenschutzmittel sowie als medikament gegen intestinale entzuendungen
DE4025387A1 (de) * 1990-08-10 1992-02-13 Hoechst Ag Substituierte pyrimidin-derivate, verfahren zu ihrer herstellung und ihre verwendung als reagenzien
US6312723B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Pharmaceutical unit dosage form
US6780880B1 (en) 1999-08-26 2004-08-24 Robert R. Whittle FT-Raman spectroscopic measurement
US6262085B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6326384B1 (en) 1999-08-26 2001-12-04 Robert R. Whittle Dry blend pharmaceutical unit dosage form
US6268385B1 (en) 1999-08-26 2001-07-31 Robert R. Whittle Dry blend pharmaceutical formulations
US6262086B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Pharmaceutical unit dosage form
US6312712B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Method of improving bioavailability
US6316020B1 (en) 1999-08-26 2001-11-13 Robert R. Whittle Pharmaceutical formulations
US6369087B1 (en) 1999-08-26 2002-04-09 Robert R. Whittle Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE416649B (sv) * 1974-05-16 1981-01-26 Haessle Ab Forfarande for framstellning av foreningar som paverkar magsyrasekretionen
US4359465A (en) * 1980-07-28 1982-11-16 The Upjohn Company Methods for treating gastrointestinal inflammation
EP0174717B1 (en) * 1984-07-06 1992-01-22 FISONS plc Benzimidazoles, and their production formulation and use as gastric acid secretion inhibitors
EP0178438A1 (en) * 1984-09-19 1986-04-23 Beecham Group Plc Novel compounds
FR2593178B1 (fr) * 1986-01-20 1988-04-29 Esteve Labor Dr Derives de 2-benzimidazolylalkylthio (ou sulfinyle ou sulfonyle) leur preparation et leur application en tant que medicaments.

Also Published As

Publication number Publication date
EP0198583A1 (en) 1986-10-22
IL78026A (en) 1990-07-26
AU5412986A (en) 1986-09-11
GR860596B (en) 1986-06-26
PH23532A (en) 1989-08-25
DK8600939A (https=) 1986-09-06
FI860909A0 (fi) 1986-03-04
DK93986A (da) 1986-09-06
FI860909A7 (fi) 1986-09-06
HUT40111A (en) 1986-11-28
PT82135B (en) 1988-06-24
PH23115A (en) 1989-04-19
ZW4786A1 (en) 1987-09-16
PT82135A (en) 1986-04-01
HU195962B (en) 1988-08-29
DK93986D0 (da) 1986-02-28
ES8707949A1 (es) 1987-09-01
JO1443B1 (en) 1988-03-10
ES552617A0 (es) 1987-09-01
NZ215362A (en) 1989-01-06
AU578141B2 (en) 1988-10-13
NO860830L (https=) 1986-09-08
US4777172A (en) 1988-10-11
US4820708A (en) 1989-04-11

Similar Documents

Publication Publication Date Title
CN1043348C (zh) 不对称取代的黄嘌呤、其制备方法及其作为药物组合物的应用
CN1059673C (zh) 降血脂1,4－苯并氮杂䓬－1,1－二氧化物
CN1159311C (zh) 二氢嘧啶类化合物
CN1029231C (zh) 三唑类抗霉菌剂的制备方法
CN1033380A (zh) 化合物
CN1095375A (zh) 新的磺酰胺
CN1264382A (zh) 新的化合物
CN1128263A (zh) 具有药理学活性的吡咯并嘧啶类衍生物
CN1227553A (zh) 双环嘧啶衍生物以及其作为抗凝血剂的用途
HK1046134B (zh) 新的硫辛酸衍生物、其製備方法、其作為藥物的應用和含有這些衍生物的藥物組合物
CN86102398A (zh) 取代苯并咪唑衍生物的制备方法
CN1127498C (zh) 吡啶衍生物、制备吡啶衍生物的方法及其中间体
CN1221407A (zh) 氨基异喹啉和氨基噻吩并吡啶衍生物及其作为抗炎剂的用途
CN1030452C (zh) 2-氨基嘧啶酮衍生物的制备方法
CN1049500A (zh) 苯并吡喃化合物，其生产方法及药物组合物
CN1231472C (zh) 嘧啶无环核苷衍生物、其制备方法及其用途
CN1013445B (zh) 苯并咪唑衍生物的制备方法
CN1503797A (zh) 吡啶并嘧啶或二氮杂萘衍生物
CN87108111A (zh) 一种新颖的咪唑衍生物及其制备方法
CN1277820C (zh) 作为单胺氧化酶b的抑制剂的邻苯二甲酰亚氨基衍生物
CN1044906C (zh) 3(2h)－哒嗪酮衍生物,其制备方法及其组合物
CN1095714A (zh) 2，3-二氮杂萘酮衍生物
CN1633418A (zh) 具有内皮素拮抗剂活性的芳烷烃－磺胺类化合物
CN1483035A (zh) 氨磺酰基噻吩并嘧啶
CN100347173C (zh) 具有免疫调制活性的吡唑并喹啉

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C01 Deemed withdrawal of patent application (patent law 1993)
WD01 Invention patent application deemed withdrawn after publication